Top

Jose Alejandro Rauh-Hain, M.D., M.P.H.

Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery

About Dr. Jose Alejandro Rauh-Hain

Dr. Rauh-Hain is a Gynecologic Oncologist on staff at the University of Texas MD Anderson Cancer Center. He was born and raised in Mexico City, Mexico and received his medical degree from Universidad Panamericana School of Medicine. After graduating from medical school, Dr. Rauh-Hain accepted an opportunity to work as a research fellow at the Massachusetts General Hospital. He conducted basic science research in the laboratory and performed clinical studies looking for biomarkers for early detection of preeclampsia. Afterwards he was accepted in the combined Obstetrics and Gynecology Residency Program at the Massachusetts General Hospital and Brigham and Women's Hospital, Harvard Medical School. Following residency, he completed a fellowship in Gynecologic Oncology at the Massachusetts General Hospital, Harvard Medical School. He completed a Masters in Public Health (MPH) at the Harvard School of Public Health and a post-doctoral fellowship in the Program in Cancer Outcomes Research Training Program. He served as faculty member in the Division of Gynecologic Oncology the Massachusetts General Hospital and was an Assistant Professor at Harvard Medical School before joining the University of Texas MD Anderson Cancer Center. His interests include the surgical treatment of gynecologic malignancies and the management of rare gynecologic tumors. He is also interested in descriptive and intervention research studies conducted in real-world clinical settings that may possibly reveal the effectiveness of strategies to reduce well-documented disparities in gynecological cancer and improve care of young women with cancer.

Meet Jose Alejandro Rauh-Hain, M.D.

In the News

2019 Andrew Sabin Family Fellows share passion for Making Cancer History

Minimally invasive surgery associated with worse survival for women with cervical cancer compared to open hysterectomy

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, UT MD Anderson Cancer Center, Houston, TX

Associate Professor, Department of Health Services Research, UT MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Associate Professor, Department of Health Services Research, UT MD Anderson Cancer Center, Houston, TX

Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, UT MD Anderson Cancer Center, Houston, TX

Clinical Interests

Ovarian cancer surgery and management

Endometrial cancer surgery and management

Cervical cancer surgery and management

Minimally invasive surgery

Pelvic reconstructive surgery

Fertility preservation for cancer patients

Health disparities among minority women

Rare gynecologic cancers

Clinical trial design

Education & Training

Degree-Granting Education

2017	Harvard School of Public Health, Boston, Massachusetts, US, MPH in Clinical Effectiveness Tract
2004	Universidad Panamericana, Mexico City, MX, MD

Postgraduate Training

2012-2015	Clinical Fellowship, Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
2008-2012	Clinical Residency, Obstetrics and Gynecology, Brigham and Women’s Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
2006-2008	Research Fellowship, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Licenses & Certifications

2019	American Board of Obstetrics and Gynecology, Gynecologic Oncology
2017	Texas Medical Board
2016	American Board of Obstetrics and Gynecology

Experience & Service

Faculty Academic Appointments

Assistant Professor, Department of Gynecologic Oncology and Reproductive Medicine, UT MD Anderson Cancer Center, Houston, TX, 2017 - 2021

Assistant Professor, Department of Health Services Research, UT MD Anderson Cancer Center, Houston, TX, 2017 - 2021

Assistant Professor, Department of Gynecologic Oncology and Reproductive Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2017 - 2017

Instructor, Department of Gynecologic Oncology and Reproductive Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, TX, 2015 - 2017

Administrative Appointments/Responsibilities

Co-Chair, Gynecologic Oncology Fellows/ Allied Health Research Network, Boston, MA, 2013 - 2014

Teaching Chief Resident, Brigham and Women’s Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2011 - 2012

Other Professional Positions

Co-Director, Ovarian Cancer Working Group, Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, TX, 2020 - 2024

Department Representative, Harris Health Cancer Committee, Houston, TX, 2019 - 2023

Director, Department of Gynecologic Oncology LBJ research program, MD Anderson Cancer Center, Houston, TX, 2019 - 2023

Clinical & Research Appointment, The Harris Health System - Lyndon B. Johnson Hospital, Houston, TX, 2019 - Present

Intramural Institutional Committee Activities

Member, Pharmacy & Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present

Extramural Institutional Committee Activities

Member, Division of Surgery Diversity, Equity, & Inclusion Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2023

Member, Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present

Editorial Activities

Associate Editor, Gynecologic Oncology, 2022 - Present

Editorial Board Member, International Journal of Gynecological Cancer, 2019 - 2022

Section Editor, UptoDate

Honors & Awards

2022	2022 GOG Foundation Scholar Investigator Award, GOG Foundation, Philadelphia, Pennsylvania
2022	FY22 Faculty Scholar Award, UT MD Anderson Cancer Center, Houston, Texas
2019	American Association of Obstetricians and Gynecologists Foundation Scholarship Award, American Association of Obstetrics and Gynecologists Foundation
2019	Sabin Fellow, Andrew Sabin Faculty
2019	Sister Institution Network, Sister Institution Network Fund
2015	Francoise Hermann Foundation/Massachusetts General Hospital Cancer Center Award Program, Massachusetts General Hospital, Harvard Medical School
2010	Resident Scholar Award, Association of Professors in Obstetrics and Gynecology
2008 - 2011	Outstanding Teacher in Obstetrics and Gynecology, Harvard Medical School
2003 - 2004	Honors Sub-Internship, Hospital Escandon
2003 - 2004	Chief Sub-Intern, Hospital Escandon
2003 - 2004	Sub-Intern of the Year, Hospital Escandon

Professional Memberships

Society of Gynecologic Oncology Health Policy Socioeconomic Committee

2018 - Present

Society of Gynecologic Oncology Diversity & Inclusion Task Force

2018 - 2019

International Gynecologic Cancer Society Gyn Onc Education Workshop

2018 - Present

Society of Gynecologic Oncology Payment Reform Taskforce

2018 - Present

Society of Gynecologic Oncologists

2012 - Present

The American Association of Gynecologic Laparoscopists

2011 - 2015

Massachusetts Medical Society

2009 - 2017

American College of Obstetricians and Gynecologists

2006 - Present

Selected Presentations & Talks

Local Presentations

2025. Primary surgery vs. Neoadjuvant chemotherapy in Advanced Stage Ovarian Cancer. Invited. Houston, Texas, US.
2025. Management of locally advanced cancer. Invited. Gynecology Integration Retreat. Houston, Texas, US.
2024. MIS – Ovary. Invited. Society of Pelvic Surgeons 2024. Houston, Texas, US.
2023. Cervical Cancer Management. Invited. A Comprehensive Board Review in Hematology and Medical Oncology. Houston, Texas, US.
2022. Ovarian Cancer Updates. Invited. Ovarian Cancer Updates. Houston, Texas, US.
2022. Cervical Cancer Management. Invited. A Comprehensive Board Review in Hematology and Medical Oncology. Houston, Texas, US.
2022. Moving beyond identification of cancer care disparities. Invited. Grand Rounds Department of Epidemiology. Houston, Texas, US.
2021. Moving beyond identification of cancer care disparities: Cascade Genetic Testing. Invited. Sabin Fellow Presentation. Houston, Texas, US.
2021. Cancer Care Disparities. Invited. Cancer Care Disparities. Houston, Texas, US.
2021. Cervical Cancer Management. Invited. A Comprehensive Board Review in Hematology and Medical Oncology. Houston, Texas, US.
2021. Disparities Research at LBJ Hospital. Invited. Disparities Research at LBJ Hospital. Houston, Texas, US.
2019. Updates in Cancer Disparities Research. Invited. Updates in Cancer Disparities Research. Houston, Texas, US.
2019. Health Services Research with Administrative Databases. Invited. Health Services Research with Administrative Databases. Houston, Texas, US.
2019. Using Big Data to Understand Trends in MIS Gyn Surgery. Invited. MD Anderson Advances in Robotic and Minimally Invasive Surgery in Gynecology Meeting. Houston, Texas, US.
2017. Early Detection of Ovarian Cancer. Invited. Grand Rounds Department of Obstetrics & Gynecology. Boston, Massachusetts, US.
2016. Early Detection of Ovarian Cancer. Invited. Grand Rounds Department of Obstetrics & Gynecology. Boston, Massachusetts, US.
2016. Early Detection of Ovarian Cancer. Invited. Grand Rounds Department of Obstetrics & Gynecology. Salem, Massachusetts, US.
2015. Management of Abnormal Pap smears. Invited. Grand Rounds Department of Obstetrics & Gynecology. Northampton, Massachusetts, US.
2010. Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: A Reasonable Option?. Invited. Grand Rounds Department of Obstetrics & Gynecology. Boston, Massachusetts, US.
2009. Early Detection of Ovarian Cancer, Myth or Reality?. Invited. Grand Rounds Department of Obstetrics & Gynecology. Boston, Massachusetts, US.
2009. Deep Venous Thrombosis in Pregnancy. Invited. Grand Rounds Department of Obstetrics & Gynecology. Boston, Massachusetts, US.
2009. Vulvar Disease. Invited. Grand Rounds Department of Obstetrics & Gynecology. Boston, Massachusetts, US.

Regional Presentations

2024. Moving beyond identification of cancer care disparities (Untapping the potential of Health Services Research). Invited. Invitation for virtual presentation to the Northwestern Quality Improvement Research and Education in Surgery, US.
2015. Management and Outcomes for Elderly Women with High-Grade Endometrial Cancer. Conference. 35th Annual New England Association of Gynecologic Oncologist Meeting. Kennebunkport, Maine, US.
2015. Laparoscopic Staging for Stage I Ovarian Cancer: An Analysis of the National Cancer Database. Conference. 35th Annual New England Association of Gynecologic Oncologist Meeting. Kennebunkport, Maine, US.
2014. Racial disparities and Trends in Treatment of High-Grade Endometrial Cancer in the Medicare Population. Conference. 34th Annual New England Association of Gynecologic Oncologist Meeting. Newport, Rhode Island, US.
2014. Trends in Treatment of Uterine Clear Cell Carcinoma in the Medicare Population. Conference. 34th Annual New England Association of Gynecologic Oncologist Meeting. Newport, Rhode Island, US.
2014. Trends in Treatment of Uterine Serous Cancer in the Medicare Population. Conference. 34th Annual New England Association of Gynecologic Oncologist Meeting. Newport, Rhode Island, US.
2014. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared to fallopian tube cancer. Conference. 34th Annual New England Association of Gynecologic Oncologist Meeting. Newport, Rhode Island, US.
2013. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time. Conference. 33rd Annual New England Association of Gynecologic Oncologist Meeting. Westbrook, Connecticut, US.
2013. Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer. Conference. 33rd Annual New England Association of Gynecologic Oncologist Meeting. Westbrook, Connecticut, US.
2012. Platinum resistance in noeadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. Conference. 32nd Annual New England Association of Gynecologic Oncologist Meeting. Bar Harbor, Maine, US.
2010. Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer. Conference. 2010 Massachusetts American College of Obstetrics and Gynecology Annual Meeting. Boston, MA, US.
2010. Low grade endometrial stromal sarcoma of the uterus: analysis of 29 patients. Conference. 30th Annual New England Association of Gynecologic Oncologist Meeting. Kennebunkport, Maine, US.
2008. Does Bowel Obstruction at the Time of Primary Presentation Affect Prognosis in Ovarian Cancer?. Conference. 28th Annual New England Association of Gynecologic Oncologist Meeting. Cape Cod, Massachusetts, US.

National Presentations

2025. Fertility Preservation Gynecologic Cancers. Invited. 17th Annual Oncofertility Consortium Conference. Detroit, Michigan, US.
2024. Pathology and Genetics of Lynch Syndrome. Invited. Intensive Course: Cancer Genetics, PR.
2024. Minimally Invasive Surgery for the Management of Women with Ovarian Cancer. Invited. 55th Annual Meeting on Women’s Cancer. San Diego, California, US.
2023. Moving beyond identification of cancer care disparities (Untapping the potential of Health Services Research). Invited. Grand Rounds Department of Obstetrics & Gynecology. Boston, Massachusetts, US.
2023. Moving beyond identification of cancer care disparities (Untapping the potential of Health Services Research). Invited. The University of Texas Rio Grande Valley (UTRGV) SOM Research Seminar Speaker Series. McAllen, Texas, US.
2023. Advancing Precision Cancer Surgery by De-escalating the Surgical Treatment of Women with Localized Cervical Cancer. Invited. American Society of Clinical Oncology 2023 Annual Meeting. Chicago, Illinois, US.
2022. Health Services Research with Administrative Databases. Invited. 53rd Annual Meeting on Women’s Cancer. Phoenix, Arizona, US.
2021. Moving beyond identification of cancer care disparities (Untapping the potential of Health Services Research). Invited. Grand Rounds Department of Obstetrics & Gynecology. Miami, Florida, US.
2021. Moving beyond identification of cancer care disparities (Untapping the potential of Health Services Research). Invited. Grand Rounds Department of Obstetrics & Gynecology. New York City, New York, US.
2020. Moving beyond identification of cancer care disparities (Untapping the potential of Health Services Research). Invited. Grand Rounds Department of Obstetrics & Gynecology. Madison, Wisconsin, US.
2020. Moving beyond identification of cancer care disparities (Untapping the potential of Health Services Research). Invited. Grand Rounds Department of Obstetrics & Gynecology. Morgantown, West Virginia, US.
2019. American Association of Obstetricians and Gynecologists Foundation Scholarship Award. Invited. 2019 American Gynecological and Obstetrical Society Annual Meeting. Chicago, Illinois, US.
2019. LANCE (Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy) Trial. Conference. Gynecologic Cancer Intergroup (GCIG) Meeting. Chicago, Illinois, US.
2019. Minimally-invasive surgery in gynecological cancer. Invited. MD Anderson Symposium, A Multidisciplinary Approach to Individualized Patient Care. Houston, Texas, US.
2018. Variation of cost and resource utilization associated with the surgical management of women with ovarian cancer. Conference. 49th Annual Meeting on Women’s Cancer. New Orleans, Louisiana, US.
2018. Health Services Research with Administrative Databases. Invited. 49th Annual Meeting on Women’s Cancer. New Orleans, Louisiana, US.
2018. Comparative effectiveness of minimally-invasive surgery in women with early-stage cervical cancer. Conference. 49th Annual Meeting on Women’s Cancer. New Orleans, Louisiana, US.
2017. Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all-cause mortality. Invited. American Association of Obstetrics and Gynecology Foundation Scholarship retreat. Denver, CO, US.
2016. Comparative Effectiveness Research in Gynecologic Oncology with the National Cancer Database. Invited. Grand Rounds Department of Obstetrics & Gynecology. Birmingham, Alabama, US.
2014. Racial disparities and Trends in Treatment of High-Grade Endometrial Cancer in the Medicare Population. Conference. Society of Gynecologic Oncology Early Career Summit. Chicago, IL, US.
2011. Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer. Conference. 42nd Annual Meeting on Women’s Cancer. Orlando, FL, US.

International Presentations

2025. Fertility Preservation for Ovarian Cancer. Invited. Annual Meeting of the International Gynecologic Cancer Society. Cape Town, ZA.
2025. Microinvasive Cervical Cancer Diagnosis and Treatment. Invited. 3rd International Congress of Oncology. Mexico City, MX.
2023. Minimally Invasive Surgery for the Management of Women with Ovarian Cancer. Invited. Next Frontiers to Cure Cancer – 2023. Sao Paulo, BR.
2023. The Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE) trial: Pilot Trial Results. Conference. International Gynecologic Cancer Society (IGCS) 2023 Meeting. Seoul, KR.
2023. The Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE) trial: Pilot Trial Results. Conference. European Society of Gynaecological Oncology Annual Meeting. Istanbul, TR.
2023. Advancing Precision Cancer Surgery by De-escalating the Surgical Treatment of Women with Localized Cervical Cancer. Invited. 2nd West Lake Summit of International Gynecological Oncology (WLSIGO), US.
2022. Minimally Invasive Surgery for Ovarian Cancer. Invited. Minimally Invasive Surgery for Ovarian Cancer. Mexico City, MX.
2022. Minimally Invasive Surgery for the Management of Women with Ovarian Cancer. Invited. AC Camago Cancer Center Meeting. Sao Paulo, BR.
2022. Advancing Precision Cancer Surgery by De-escalating the Surgical Treatment of Women with Localized Cervical Cancer. Conference. Gynecologic Oncology Grand Rounds. Mexico City, MX.
2022. Minimally Invasive Surgery for the Management of Women with Ovarian Cancer. Invited. International Gynecologic Cancer Society (IGCS) 2022 Meeting. New York City, US.
2022. Minimally Invasive Surgery for the Management of Women with Ovarian Cancer. Invited. 1st West Lake Summit of International Gynecological Oncology (WLSIGO), US.
2021. Intraoperative Management Adnexal Mass. Invited. Mexican Society of General Surgery Annual Meeting. Mexico City, MX.
2021. Minimally Invasive Surgery for the Management of Women with Ovarian Cancer. Invited. XIII Congreso Nacional de la Asociación Argentina de Ginecología Oncológica 2021 - Edición Online. Buenos Aires, AR.
2021. Minimally Invasive Surgery for Ovarian Cancer. Invited. Asia Pacific Ovarian Cancer Laparotomic and Laparoscopic Operation Symposium, US.
2020. Can we trust the TRUST trial?. Invited. International Gynecologic Cancer Society Meeting 2020, US.
2020. Is Laparoscopic Interval Cytoreductive Surgery Feasible? LANCE Phase lll Clinical Trial. Invited. International Academic Oncology Virtual Meetings, National Institute of Cancer Mexico. Mexico City, MX.
2020. Minimally Invasive Surgery for Ovarian Cancer. Invited. International Meeting Gynecologic Oncology. Mexico City, MX.
2019. Management of adnexal mass and ovarian cancer for general gynecologists. Invited. Annual Meeting of the Guatemala Society of Obstetrics and Gynecology. Guatemala City, GT.
2019. Updates on Sentinel Node Mapping Gynecologic Oncology. Invited. Annual Meeting of the Guatemala Society of Obstetrics and Gynecology. Guatemala City, GT.
2019. Comparative effectiveness of minimally-invasive surgery in women with early-stage cervical cancer. Conference. Mexican Society of Gynecologic Oncology Annual Meeting. Queretaro, MX.
2019. Updates on Sentinel Node Mapping Gynecologic. Invited. Selected Topics in Gynecologic Oncology Meeting, National Institute of Cancer Mexico. Cancun, MX.
2019. LANCE (Laparoscopic cytoreduction After Neoadjuvant Chemotherapy) Trial. Conference. Gynecologic Cancer Intergroup (GCIG) Meeting. Athens, GR.
2019. Minimally-invasive surgery in gynecological cancer. Invited. Annual Meeting of the Guatemala Society of Obstetrics and Gynecology. Guatemala City, GT.
2018. LACC Trial Results: Impact on Future of Minimally Radical Hysterectomy. Invited. International Gynecologic Cancer Society (IGCS) 2018 Meeting. Kyoto, JP.
2018. Fertility Sparing Surgery in Young Women with Ovarian Cancer. Invited. International Gynecologic Oncology Course 2018. Mexico City, MX.
2018. Prophylactic Surgery for Gynecological Cancers. Invited. International Gynecologic Oncology Course 2018. Mexico City, MX.
2018. Comparative effectiveness of minimally-invasive surgery in women with early-stage cervical cancer. Invited. International Gynecologic Oncology Course 2018. Mexico City, MX.
2018. Minimally-invasive surgery in women with early-stage cervical cancer. Conference. 15th Annual Meeting on Breast Disease. Merida, MX.
2018. Adjuvant treatments in uterine sarcomas. Invited. MD Anderson Spain Gynecologic Oncology Conference. Madrid, ES.
2018. Robotic Surgery Gynecological Cancers. Invited. MD Anderson Spain Gynecologic Oncology Conference. Madrid, ES.
2018. Comparative effectiveness of minimally-invasive surgery in women with early-stage cervical cancer. Conference. Selected Topics in Gynecologic Oncology Meeting 2018. Cancun, MX.
2016. Adjuvant treatments in uterine sarcomas. Invited. Selected Topics in Gynecologic Oncology Meeting 2016. Cancun, MX.
2011. Clinical features and chemotherapy outcomes in adolescent patients with gestational trophoblastic neoplasia compare to adult women. Conference. 17th World Congress on Gestational Trophoblastic Diseases. Budapest, HU.

Formal Peers

2024. Cervical Cancer Management. Houston, Texas, US.
2023. Upfront Management Ovarian Cancer. Houston, Texas, US.
2023. Experiences from Designing and Implementing a Surgical Trial. Houston, Texas, US.
2022. How to get a manuscript published. Houston, Texas, US.
2022. Experiences from Designing and Implementing a Surgical Trial. Houston, Texas, US.
2022. Upfront Management Ovarian Cancer. Houston, Texas, US.
2021. Upfront Management Ovarian Cancer. Houston, Texas, US.
2020. Upfront Management Ovarian Cancer. Houston, Texas, US.
2020. Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer. Invited. Houston, Texas, US.
2019. Upfront Management Ovarian Cancer. Houston, Texas, US.
2019. Health Services Research with Administrative Databases. Houston, Texas, US.
2016. How to get a manuscript published. Invited. Boston, MA, US.
2015. Management of Abnormal Pap smears. Invited. Boston, Massachusetts, US.

Less

Grant & Contract Support

Date:	2024 - Present
Title:	Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE) Trial
Funding Source:	Department of Defense
Role:	PI
ID:	OC230078

Date:	2023 - Present
Title:	Health equity in fertility specialty care among cancer survivors
Funding Source:	NIH/NCI
Role:	PI
ID:	1 R01 MD017999-01

Date:	2023 - Present
Title:	Evaluation and adaptation of an educational video intervention to improve cascade genetic testing among medically underserved Texans
Funding Source:	Quasi Endowment (QE) Community Outreach and Engagement Fund for Underserved Texan
Role:	PI

Date:	2023 - Present
Title:	IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) intervention
Funding Source:	American Cancer Society (ACS)
Role:	PI
ID:	AHEAD-DBG-23-1143580-01-CPSH

Date:	2023 - Present
Title:	Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
Funding Source:	NIH
Role:	Co-I
ID:	R37CA276322

Date:	2023 - Present
Title:	Minimally invasive surgery for advanced ovarian cancer: a pilot randomized trial
Funding Source:	Department of Defense
Role:	Co-I

Date:	2023 - Present
Title:	IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
Funding Source:	Edmee Firth Prize for Outcomes Research in Ovarian Cancer
Role:	PI

Date:	2021 - 2023
Title:	Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy (LANCE) Trial
Funding Source:	MDA Institutional Research Grant
Role:	PI

Date:	2019 - 2021
Title:	Ovarian Cancer Omics Consortium
Funding Source:	Department of Defense (DOD)
Role:	Early Career Investigator

Date:	2019 - 2021
Title:	Barriers to Cascade Testing Among Low-Income Underserved Women with Hereditary Gynecological Cancers
Funding Source:	The Andrew Sabin Family Foundation Fellowship
Role:	PI

Date:	2019 - 2021
Title:	Environmental Scan of Hereditary Cancer Genetics Services in International Gynecologic Oncology Settings for Quality Improvement Dissemination
Funding Source:	SINF
Role:	PI

Date:	2018 - 2024
Title:	Obstetrical and Oncological Outcomes Among Reproductive Age Women with Gynecological and Breast Cancer
Funding Source:	NIH/NCI
Role:	PI
ID:	K08CA234333

Date:	2016 - 2018
Title:	First-line Treatment Trends and Costs in Women with Epithelial Ovarian Cancer / American Association of Obstetricians and Gynecologists Foundation Scholarship
Funding Source:	American Association of Obstetricians and Gynecologists Foundation Scholarship
Role:	PI

Date:	2015 - 2017
Title:	First-line Treatment Trends and Costs in Women with Epithelial Ovarian Cancer / The Clinician-Teacher Development Award
Funding Source:	Massachusetts General Hospital Center for Diversity and Inclusion
Role:	PI

Date:	2015 - 2017
Title:	The Program in Cancer Outcomes Research Training
Funding Source:	Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School
Role:	Postdoctoral Fellow

Selected Publications

Peer-Reviewed Articles

Perez L, Kulkarni A, Rauh-Hain J, Keenahan L, Chandler I, Chapman-Davis E, Frey M, Rosenberg S. Decision-making surrounding ovarian cancer risk-reducing surgery: perspectives from a diverse population, 2026. e-Pub 2026. PMID: 41589845.
Abel MK, Kanbergs A, Wu CF, Perkins G, Agusti N, Viveros-Carreno D, Wilke RN, Barajas K, Rauh-Hain JA, Melamed A. Racial Differences in Live-Birth Outcomes After a Breast Cancer Diagnosis. O G Open 2(6):e133, 2025. e-Pub 2025. PMID: 41235395.
Kanbergs A, Agusti N, Perkins G, Wu CF, Viveros-Carreno D, Iniesta MD, Barajas K, Melamed A, Rauh-Hain JA, Wilke RN. Trends and Clinical Predictors in Ovarian Preservation in Patients with Low-Risk Endometrial Cancer. Am J Obstet Gynecol 234(3):650-667, 2025. e-Pub 2025. PMID: 41223960.
Wilke RN, Agusti N, Wu CF, Iniesta MD, Manning WB, Viveros-Carreno D, Kurian AW, Rauh-Hain JA, Melamed A. Association between germline BRCA1 pathogenic variants and uterine serous carcinoma among women with breast cancer: a population-based analysis. Am J Obstet Gynecol 234(2):e37-e41, 2025. e-Pub 2025. PMID: 41109496.
Kanbergs A, Perkins G, Wu CF, Melamed A, Agusti N, Viveros-Carreno D, Barajas K, Bercow AS, Rauh-Hain JA, Nitecki Wilke R. Effect of Geospatial and Sociodemographic Factors on Live Birth After Fertility-Sparing Treatment for Breast and Gynecologic Cancers. O G Open 2(5):e123, 2025. e-Pub 2025. PMID: 41142663.
Agusti N, Viveros-Carreno D, Rauh-Hain JA. Limitations in Adjuvant Chemoradiotherapy Study-Reply. JAMA Oncol 11(9):1094, 2025. e-Pub 2025. PMID: 40638127.
Pannekoek A, Melamed A, Rauh-Hain JA, Ruan M, Lipsitz SR, Siguo L, Molina G. Cross-specialty impact in the adoption of minimally invasive surgery in abdominal surgical oncology at the hospital level. J Robot Surg 19(1):366, 2025. e-Pub 2025. PMID: 40632432.
Abel MK, Mazina V, Bregar AJ, Gockley AA, Del Carmen MG, Eisenhauer EL, Wilke RN, Rauh-Hain JA, Dottino JA, Melamed A. Neoadjuvant Chemotherapy, Case Volume, and Mortality in Advanced Ovarian Cancer. JAMA Netw Open 8(7):e2523434, 2025. e-Pub 2025. PMID: 40711787.
Agusti N, Barajas K, Rauh-Hain JA. Minimally invasive surgery in advanced and recurrent ovarian cancer: current evidence and future directions. Curr Opin Oncol 37(5):478-486, 2025. e-Pub 2025. PMID: 40511607.
Wilke, RN, Wu, C, Kanbergs, A, Bercow, AS, Garcia, NA, Viveros-Carreño, D, Zamorano, AS, Rauh-Hain, JA, Melamed, A. Disparities in facility-level adoption of minimally invasive interval debulking surgery for advanced ovarian cancer. Gynecologic oncology 197:11-18, 2025. e-Pub 2025. PMID: 40250029.
Agusti N, Viveros-Carreno D, Wu CF, Wilke RN, Kanbergs A, Barajas K, Zamorano AS, Pareja R, Melamed A, Rauh-Hain JA. Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer. JAMA Oncol 11(5):511-518, 2025. e-Pub 2025. PMID: 40079948.
Kanbergs A, Melamed A, Viveros-Carreno D, Wu CF, Wilke RN, Zamorano A, Paladuga K, Havrilesky L, Rauh-Hain JA, Agusti N. Surgical Deescalation Within Gynecologic Oncology. JAMA Netw Open 8(1):e2453604, 2025. e-Pub 2025. PMID: 39775807.
Bednar, EM, Wilke, RN, Jorgensen, K, Walsh, MT, Nutt, S, Lu, KH, Nóbrega, L, De Souza, AD, da Silva Oliveira, G, da Cunha Andrade, CM, Purizaca-Rosillo, N, Mora, P, López Blanco, A, Gallardo-Alvarado, LN, De Leon, DC, Rauh-Hain, JA. Feasibility of an environmental scan–based approach to collecting information about factors impacting cancer genetics services in Latin American countries. Journal of Community Genetics 15(6):681-686, 2024. e-Pub 2024. PMID: 39397225.
Rauh-Hain, JA, Melamed, A, Pareja, R, May, T, Sinno, AK, McNally, L, Horowitz, NS, De Iaco, P, Michener, C, Van Lonkhuijzen, LR, Iniesta-Donate, M, Yuan, Y, Ramirez, PT, Fagotti, A. Laparoscopic Cytoreduction after Neoadjuvant Chemotherapy in High-Grade Epithelial Ovarian Cancer. JAMA Network Open 7(11), 2024. e-Pub 2024. PMID: 39570589.
Sehouli, J, Boer, J, Brand, AH, Oza, A, O’Donnell, J, Bennett, K, Glaspool, R, Lee, CK, Ethier, JL, Harter, P, Seebacher-Shariat, V, Chang, TC, Cohen, PA, Van Gorp, T, Chávez-Blanco, A, Welch, S, Hranovska, H, O'Toole, S, Lok, C, Madariaga, A, Rauh-Hain, JA, Fidalgo, AP, Tan, DS, Michels, J, Pothuri, B, Fujiwara, N, Rosengarten, O, Nishio, H, Kim, SI, Mukopadhyay, A, Piovano, E, Cecere, SC, Kohn, E, Mukherjee, U, Nasser, S, Lindemann, K, Croke, J, Chen, X, Geissler, F, Bookman, M. How to optimize and evaluate diversity in gynecologic cancer clinical trials. International Journal of Gynecological Cancer 34(11):1677-1684, 2024. e-Pub 2024. PMID: 39496422.
Kanbergs A, Clapp M, Wu CF, Melamed A, Agusti N, Viveros-Carreno D, Zamorano AS, Virili F, Rauh-Hain JA, Nitecki Wilke R. Cancer diagnosis during pregnancy is associated with severe maternal and neonatal morbidity. Am J Obstet Gynecol 232(5):466.e1-466.e29, 2024. e-Pub 2024. PMID: 39447820.
Nitecki Wilke R, Liu J, Westin SN, Fellman BM, Sims TT, Pham M, Rangel K, Sey E, Rauh-Hain JA, Lu KH, Sood AK, Fleming ND. The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvant chemotherapy. Int J Gynecol Cancer 35(11), 2024. e-Pub 2024. PMID: 39414313.
Bednar EM, Nitecki Wilke R, Jorgensen K, Walsh MT Jr, Nutt S, Lu KH, Nobrega L, De Souza APSD, da Silva Oliveira G, da Cunha Andrade CEM, Purizaca-Rosillo N, Mora P, Lopez Blanco A, Gallardo-Alvarado LN, Cantu-de Leon D, Rauh-Hain JA. Feasibility of an environmental scan-based approach to collecting information about factors impacting cancer genetics services in Latin American countries. J Community Genet, 2024. e-Pub 2024. PMID: 39397225.
Bercow A, Stewart T, Bregar AJ, Gockley A, Mazina V, Rauh-Hain JA, Melamed A. Utilization of Primary Cytoreductive Surgery for Advanced-Stage Ovarian Cancer. JAMA Netw Open 7(10):e2439893, 2024. e-Pub 2024. PMID: 39412808.
Viveros-Carreno D, Agusti N, Wu CF, Melamed A, Nitecki Wilke R, Kanbergs A, Pareja R, Zamorano AS, Rauh-Hain JA. Survival After Simple Compared With Radical Hysterectomy for Patients With Early-Stage Cervical Cancer. Obstet Gynecol 145(1):99-107, 2024. e-Pub 2024. PMID: 39326049.
Barakzai SK, Bregar AJ, Del Carmen MG, Eisenhauer EL, Goodman A, Rauh-Hain JA, Gockley AA, Melamed A. The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study. Gynecol Oncol 190:119-123, 2024. e-Pub 2024. PMID: 39178527.
Knisely A, Wu CF, Kanbergs A, Agusti N, Jorgensen KA, Melamed A, Giordano SH, Rauh-Hain JA, Nitecki Wilke R. Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare. Int J Gynecol Cancer 34(11):1661-1670, 2024. e-Pub 2024. PMID: 39084695.
Agusti N, Viveros-Carreno D, Melamed A, Pareja R, Kanbergs A, Wu CF, Nitecki R, Colbert L, Rauh-Hain JA. Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer. Int J Gynecol Cancer 34(8):1149-1155, 2024. e-Pub 2024. PMID: 38925662.
Wilke RN, Bednar EM, Pirzadeh-Miller S, Lahiri S, Scarinci IC, Leath Iii CA, Frey MK, Lu KH, Rauh-Hain JA. Cascade genetic testing: an underutilized pathway to equitable cancer care?. Fam Cancer 23(2):141-145, 2024. e-Pub 2024. PMID: 38748383.
Kanbergs A, Jorgensen K, Agusti N, Viveros-Carreno D, Wu CF, Nitecki R, Harris JA, Woodard T, Ramphul R, Rauh-Hain JA. Patient Location and Disparities in Access to Fertility Preservation for Women With Gynecologic or Breast Cancer. Obstet Gynecol 143(6):824-834, 2024. e-Pub 2024. PMID: 38574368.
Huang Y, Rauh-Hain JA, McCoy TH, Hou JY, Hillyer G, Ferris JS, Hershman D, Wright JD, Melamed A. Comparing survival of older ovarian cancer patients treated with neoadjuvant chemotherapy versus primary cytoreductive surgery: Reducing bias through machine learning. Gynecol Oncol 186:9-16, 2024. e-Pub 2024. PMID: 38554626.
Bednar EM, Paiz KA, Lu KH, Soares Dias De Souza AP, Oliveira G, Andrade CEEMDC, Gallardo L, Rubio-Cordero J, Cantu-de-Leon D, Rauh-Hain JA. Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico. Int J Gynecol Cancer 34(7):1020-1026, 2024. e-Pub 2024. PMID: 38453180.
Jorgensen KA, Agusti N, Wu CF, Kanbergs A, Pareja R, Ramirez PT, Rauh-Hain JA, Melamed A. Fertility-sparing surgery vs standard surgery for early-stage cervical cancer: difference in 5-year life expectancy by tumor size. Am J Obstet Gynecol 230(6):663.e1-663.e13, 2024. e-Pub 2024. PMID: 38365097.
Bednar, EM, Rauh-Hain, JA, Garcia, J, de Aguinaga, N, Powell, MA, Peral, SL, Wilke, RN, Jorgensen, K, Rudy, NL, Lu, KH, Leath, CA, Scarinci, I. Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations—A Qualitative Study. Cancer Prevention Research 17(1):19-28, 2024. e-Pub 2024. PMID: 37913800.
Pham, T, Lapid, D, Schmeler, KM, Rauh-Hain, JA, Leon, MG. Retroperitoneal Hematoma as an Atypical Presentation of Choriocarcinoma. Case Reports in Oncology 16(1):1274-1279, 2023. e-Pub 2023. PMID: 37928866.
Jorgensen, K, Denham, CJ, Kanbergs, A, Wu, C, Wilke, RN, Agusti, N, Meernik, C, Melamed, A, Rauh-Hain, JA. All-cause and cancer-specific mortality after fertility-sparing surgery for stage IA and IC epithelial ovarian cancer. Gynecologic oncology 178:60-68, 2023. e-Pub 2023. PMID: 37801736.
Meernik, C, Engel, SM, Wardell, A, Baggett, C, Gupta, P, Rodriguez-Ormaza, N, Luke, B, Baker, VL, Wantman, E, Rauh-Hain, JA, Mersereau, JE, Olshan, AF, Smitherman, AB, Cai, J, Nichols, HB. Disparities in fertility preservation use among adolescent and young adult women with cancer. Journal of Cancer Survivorship 17(5):1435-1444, 2023. e-Pub 2023. PMID: 35169982.
Abel, MK, Myers, EL, Minkin, E, Tahir, P, Haynes, AB, Wright, JD, Rauh-Hain, JA, Melamed, A. Cancer-directed surgery in patients with metastatic cancer. Cancer medicine 12(13):14072-14083, 2023. e-Pub 2023. PMID: 37309837.
Foster KI, Shaw KRM, Jin J, Westin SN, Yap TA, Glassman DM, Jazaeri AA, Rauh-Hain JA, Lee S, Fellman BM, Ju Z, Liu Y, Fleming ND, Sood AK. Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer. Cancer 129(11):1672-1680, 2023. e-Pub 2023. PMID: 36930815.
Jorgensen K, Melamed A, Wu CF, Nitecki R, Pareja R, Fagotti A, Schorge JO, Ramirez PT, Rauh-Hain JA. Minimally invasive interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapy. Gynecol Oncol 172:130-137, 2023. e-Pub 2023. PMID: 36977622.
Hoffman A, Denham CJ, Fu S, Mendoza T, Nitecki R, Jorgensen KA, Garcia J, Lamiman K, Woodard TL, Rauh-Hain JA. Assessing gaps in motherhood after cancer: development and psychometric testing of the Survivorship Oncofertility Barriers Scale. Int J Gynecol Cancer 33(5):778-785, 2023. e-Pub 2023. PMID: 37001892.
Kahn RM, Ahsan MD, Chapman-Davis E, Holcomb K, Nitecki R, Rauh-Hain JA, Fowlkes RK, Tubito F, Pires M, Christos PJ, Tkachuk K, Krinsky H, Sharaf RN, Offit K, Lipkin S, Frey MK. Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?. Fam Cancer 22(2):127-133, 2023. e-Pub 2023. PMID: 36207653.
Meernik C, Jorgensen K, Wu CF, Murphy CC, Baker VL, Brady PC, Nitecki R, Nichols HB, Rauh-Hain JA. Disparities in the use of assisted reproductive technologies after breast cancer: a population-based study. Breast Cancer Res Treat 198(1):149-158, 2023. e-Pub 2023. PMID: 36607486.
Hughes BN, Jorgensen KA, Cummings S, Morah D, Krause K, Rauh-Hain JA, Herzog TJ. Systematic mapping review of guidelines for BRCA1/2 genetic testing globally: investigating geographic and regional disparities in health equity for women and families at risk for hereditary ovarian cancer. Int J Gynecol Cancer 33(2):250-256, 2023. e-Pub 2023. PMID: 36368709.
Jorgensen K, Meernik C, Wu CF, Murphy CC, Baker VL, Jarmon P, Brady PC, Nitecki R, Nichols HB, Rauh-Hain JA. Disparities in Fertility-Sparing Treatment and Use of Assisted Reproductive Technology After a Diagnosis of Cervical, Ovarian, or Endometrial Cancer. Obstet Gynecol 141(2):341-353, 2023. e-Pub 2023. PMID: 36649345.
Bercow AS, Rauh-Hain JA, Melamed A, Mazina V, Growdon WB, Del Carmen MG, Goodman A, Bouberhan S, Randall T, Sisodia R, Bregar A, Eisenhauer EL, Minami C, Molina G. Association of hospital-level factors with utilization of sentinel lymph node biopsy in patients with early-stage vulvar cancer. Gynecol Oncol 169:47-54, 2023. e-Pub 2023. PMID: 36508758.
Melamed A, Lin YL, Hassan AM, Rauh-Hain JA, Herring B, Keating NL, Offodile AC. Trends in Episode-of-Care Spending for Cancer-Directed Surgery Among US Medicare Beneficiaries From 2011 to 2019. JAMA Surg 158(2):216-218, 2023. e-Pub 2023. PMID: 36477545.
Glassman D, Rauh-Hain JA, Tandon N, Fattahi N. Diagnostic and treatment considerations for synchronous cancer of the ovary and endometrium. Int J Gynecol Cancer 33(1):118-122, 2023. e-Pub 2023. PMID: 36603893.
Batman S, Rauh-Hain JA, Grinsfelder MO, Harrison R, Avila M, Cun H, How JA, Tandon N, Wang X, Hinchcliff E, Jazaeri AA, Schmeler KM. Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemorefractory Endometrial Carcinoma in a Patient with Lynch Syndrome: A Case Report. Case Rep Oncol 16(1):273-278, 2023. e-Pub 2023. PMID: 37123608.
Jorgensen K, Nitecki R, Nichols HB, Fu S, Wu CF, Melamed A, Brady P, Chavez Mac Gregor M, Clapp MA, Giordano S, Rauh-Hain JA. Obstetric and Neonatal Outcomes 1 or More Years After a Diagnosis of Breast Cancer. Obstet Gynecol 140(6):939-949, 2022. e-Pub 2022. PMID: 36357983.
Bercow AS, Rauh-Hain JA, Melamed A, Mazina V, Growdon WB, Del Carmen MG, Goodman A, Bouberhan S, Bregar A, Eisenhauer EL, Molina G, Minami C. Guideline-Discordant Care in Early-Stage Vulvar Cancer. Obstet Gynecol 140(6):1031-1041, 2022. e-Pub 2022. PMID: 36357957.
Frey MK, Ahsan MD, Badiner N, Lin J, Narayan P, Nitecki R, Rauh-Hain JA, Moss H, Fowlkes RK, Thomas C, Bergeron H, Christos P, Levi SR, Blank SV, Holcomb K, Cantillo E, Sharaf RN, Lipkin S, Offit K, Chapman-Davis E. What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing. Cancer 128(24):4241-4250, 2022. e-Pub 2022. PMID: 36305018.
Huepenbecker SP, Sun CC, Fu S, Zhao H, Primm K, Rauh-Hain JA, Fleming ND, Giordano SH, Meyer LA. Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States. Int J Gynecol Cancer 32(9):1153-1163, 2022. e-Pub 2022. PMID: 36166208.
Rauh-Hain JA, Zubizarreta J, Nitecki R, Melamed A, Fu S, Jorgensen K, Brady PC, Baker VL, Chavez-MacGregor M, Giordano SH, Keating NL. Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population-based study. Cancer 128(17):3243-3253, 2022. e-Pub 2022. PMID: 35767282.
Modesitt, SC, Havrilesky, LJ, Previs, RA, Rauh-Hain, JA, Michael Straughn, J, Bakkum-Gamez, JN, Fuh, KC, Cohn, DE. Ridiculously good writing. Gynecologic Oncology Reports 42, 2022. e-Pub 2022. PMID: 35719321.
Offodile AC, Lin YL, Melamed A, Rauh-Hain JA, Kinzer D, Keating NL. Association of Maryland Global Budget Revenue With Spending and Outcomes Related to Surgical Care for Medicare Beneficiaries With Cancer. JAMA Surg 157(6):e220135, 2022. e-Pub 2022. PMID: 35385085.
Cerullo M, Lin YL, Rauh-Hain JA, Ho V, Offodile AC. Financial Impacts And Operational Implications Of Private Equity Acquisition Of US Hospitals. Health Aff (Millwood) 41(4):523-530, 2022. e-Pub 2022. PMID: 35377756.
LaFargue CJ, Handley KF, Fleming ND, Nick AM, Chelariu-Raicu A, Fellman B, Castellano T, Ogasawara A, Hom-Tedla M, Blake EA, AABA DC, Crim AK, Rauh-Hain JA, Westin SN, Coleman RL, Matsuo K, Baiocchi G, Hasegawa K, Moore K, Sood AK. Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer. Gynecol Oncol 165(1):82-89, 2022. e-Pub 2022. PMID: 35216808.
Nitecki R, Fu S, Jorgensen KA, Gray L, Lefkowits C, Smith BD, Meyer LA, Melamed A, Giordano SH, Ramirez PT, Rauh-Hain JA. Employment disruption among women with gynecologic cancers. Int J Gynecol Cancer 32(1):69-78, 2022. e-Pub 2022. PMID: 34785522.
Cham S, Li A, Rauh-Hain JA, Tergas AI, Hershman DL, Wright JD, Melamed A. Association Between Neighborhood Socioeconomic Inequality and Cervical Cancer Incidence Rates in New York City. JAMA Oncol 8(1):159-161, 2022. e-Pub 2022. PMID: 34817550.
Melamed A, Rauh-Hain JA, Gockley AA, Nitecki R, Ramirez PT, Hershman DL, Keating N, Wright JD. Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian Cancer. JAMA Oncol 7(12):1782-1790, 2021. e-Pub 2021. PMID: 34591081.
Bruera S, Lei X, Zogala R, Pundole X, Zhao H, Giordano SH, Hwang JP, Rauh-Hain JA, Suarez-Almazor ME. Cervical Cancer Screening in Women with Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 73(12):1796-1803, 2021. e-Pub 2021. PMID: 32799430.
Nitecki R, Floyd J, Lamiman K, Clapp MA, Fu S, Jorgensen K, Melamed A, Brady PC, Kaimal A, Del Carmen MG, Woodard TL, Meyer LA, Giordano SH, Ramirez PT, Rauh-Hain JA. Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Cervical Cancer. Obstet Gynecol 138(4):565-573, 2021. e-Pub 2021. PMID: 34623068.
Fleming ND, Westin SN, Rauh-Hain JA, Soliman PT, Fellman BM, Coleman RL, Meyer LA, Shafer A, Cobb LP, Jazaeri A, Lu KH, Sood AK. Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer. Gynecol Oncol 162(1):65-71, 2021. e-Pub 2021. PMID: 33838925.
Nitecki R, Fleming ND, Fellman BM, Meyer LA, Sood AK, Lu KH, Rauh-Hain JA. Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol 161(3):660-667, 2021. e-Pub 2021. PMID: 33867146.
Nitecki R, Clapp MA, Fu S, Lamiman K, Melamed A, Brady PC, Kaimal A, Del Carmen MG, Woodard TL, Meyer LA, Giordano SH, Ramirez PT, Rauh-Hain JA. Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian Cancer. Obstet Gynecol 137(6):1109-1118, 2021. e-Pub 2021. PMID: 33957660.
Offodile AC, Cerullo M, Bindal M, Rauh-Hain JA, Ho V. Private Equity Investments In Health Care: An Overview Of Hospital And Health System Leveraged Buyouts, 2003-17. Health Aff (Millwood) 40(5):719-726, 2021. e-Pub 2021. PMID: 33939504.
Rodriguez J, Rauh-Hain JA, Saenz J, Isla DO, Rendon Pereira GJ, Odetto D, Martinelli F, Villoslada V, Zapardiel I, Trujillo LM, Perez M, Hernandez M, Saadi JM, Raspagliesi F, Valdivia H, Siegrist J, Fu S, Hernandez Nava M, Echeverry L, Noll F, Ditto A, Lopez A, Hernandez A, Pareja R. Oncological outcomes of laparoscopic radical hysterectomy versus radical abdominal hysterectomy in patients with early-stage cervical cancer: a multicenter analysis. Int J Gynecol Cancer 31(4):504-511, 2021. e-Pub 2021. PMID: 33504547.
Fleming ND, Westin SN, Meyer LA, Shafer A, Rauh-Hain JA, Onstad M, Cobb L, Bevers M, Fellman BM, Burzawa J, Bhosale P, Zand B, Jazaeri A, Levenback C, Coleman RL, Soliman PT, Sood AK. Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer. Int J Gynecol Cancer 31(1):92-97, 2021. e-Pub 2021. PMID: 33154095.
Nitecki R, Fu S, Lefkowits C, Smith BD, Meyer LA, Melamed A, Giordano SH, Rauh-Hain JA. Employment disruption following the diagnosis of endometrial cancer. Gynecol Oncol 160(1):199-205, 2021. e-Pub 2021. PMID: 33183765.
Nitecki R, Woodard T, Rauh-Hain JA. Fertility-Sparing Treatment for Early-Stage Cervical, Ovarian, and Endometrial Malignancies. Obstet Gynecol 136(6):1157-1169, 2020. e-Pub 2020. PMID: 33156194.
Dottino JA, He W, Sun CC, Zhao H, Fu S, Rauh-Hain JA, Suidan RS, Lu KH, Giordano SH, Meyer LA. National trends in bowel and upper abdominal procedures in ovarian cancer surgery. Int J Gynecol Cancer 30(8):1195-1202, 2020. e-Pub 2020. PMID: 32616627.
Nitecki R, Ramirez PT, Frumovitz M, Krause KJ, Tergas AI, Wright JD, Rauh-Hain JA, Melamed A. Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer: A Systematic Review and Meta-analysis. JAMA Oncol 6(7):1019-1027, 2020. e-Pub 2020. PMID: 32525511.
Lara OD, Wang Y, Asare A, Xu T, Chiu HS, Liu Y, Hu W, Sumazin P, Uppal S, Zhang L, Rauh-Hain JA, Sood AK. Pan-cancer clinical and molecular analysis of racial disparities. Cancer 126(4):800-807, 2020. e-Pub 2020. PMID: 31730714.
Harrison R, Zhao H, Sun CC, Fu S, Armbruster SD, Westin SN, Rauh-Hain JA, Lu KH, Giordano SH, Meyer LA. Body mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment. Int J Gynecol Cancer 30(2):187-192, 2020. e-Pub 2020. PMID: 31843871.
Harrison RF, He W, Fu S, Zhao H, Sun CC, Suidan RS, Woodard TL, Rauh-Hain JA, Westin SN, Giordano SH, Meyer LA. National Patterns of Care and Fertility Outcomes for Reproductive-aged Women with Endometrial Cancer or Atypical Hyperplasia. Am J Obstet Gynecol 221(5):474.e1-474.e11, 2019. e-Pub 2019. PMID: 31128110.
Suidan RS, He W, Sun CC, Zhao H, Rauh-Hain JA, Fleming ND, Lu KH, Giordano SH, Meyer LA. Total and out-of-pocket costs of different primary management strategies in ovarian cancer. Am J Obstet Gynecol 221(2):136.e1-136.e9, 2019. e-Pub 2019. PMID: 30965052.
Melamed A, Bercow AS, Bunnell K, Rauh-Hain JA, Wright JD, Rice LW, Del Carmen MG. Age-Associated Risk of 90-Day Postoperative Mortality After Cytoreductive Surgery for Advanced Ovarian Cancer. JAMA Surg 154(7):669-671, 2019. e-Pub 2019. PMID: 31066875.
Bregar A, Mojtahed A, Kilcoyne A, Kurra V, Melamed A, Growdon W, Rauh-Hain JA, Del Carmen M, Lee SI. CT prediction of surgical outcome in patients with advanced epithelial ovarian carcinoma undergoing neoadjuvant chemotherapy. Gynecol Oncol 152(3):568-573, 2019. e-Pub 2019. PMID: 30642626.
Rauh-Hain JA, Hidrue MK, Gaccione P, Melamed A, Meyer LA, Keating NL, Giordano SH, Rice LW, Birrer MJ, Del Carmen MG. Variation in resource utilization associated with the surgical management of ovarian cancer. Gynecol Oncol 152(3):587-593, 2019. e-Pub 2019. PMID: 30579568.
Lietz AP, Weaver DT, Melamed A, Rauh-Hain JA, Wright JD, Wright AA, Knudsen AB, Pandharipande PV. Potential survival benefits from optimized chemotherapy implementation in advanced ovarian cancer: Projections from a microsimulation model. PLoS One 14(9):e0222828, 2019. e-Pub 2019. PMID: 31539415.
Melamed A, Margul DJ, Chen L, Keating NL, Del Carmen MG, Yang J, Seagle BL, Alexander A, Barber EL, Rice LW, Wright JD, Kocherginsky M, Shahabi S, Rauh-Hain JA. Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. N Engl J Med 379(20):1905-1914, 2018. e-Pub 2018. PMID: 30379613.
Hicks-Courant K, Melamed A, Worley MJ, Kim YB, Schorge JO, Rauh-Hain JA. Trends in Place of Death Among Patients With Gynecologic Cancer in the United States. Obstet Gynecol 131(6):1111-1120, 2018. e-Pub 2018. PMID: 29742673.
Weaver DT, Raphel TJ, Melamed A, Rauh-Hain JA, Schorge JO, Knudsen AB, Pandharipande PV. Modeling treatment outcomes for patients with advanced ovarian cancer: Projected benefits of a test to optimize treatment selection. Gynecol Oncol 149(2):256-262, 2018. e-Pub 2018. PMID: 29486993.
Rauh-Hain JA, Melamed A, Schaps D, Bregar AJ, Spencer R, Schorge JO, Rice LW, Del Carmen MG. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies. Gynecol Oncol 149(1):4-11, 2018. e-Pub 2018. PMID: 29605048.
Melamed A, Fink G, Wright AA, Keating NL, Gockley AA, Del Carmen MG, Schorge JO, Rauh-Hain JA. Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study. BMJ 360:j5463, 2018. e-Pub 2018. PMID: 29298771.
Hinchcliff E, Melamed A, Bregar A, Diver E, Clemmer J, Del Carmen M, Schorge JO, Rauh-Hain JA. Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer. Gynecol Oncol 148(1):168-173, 2018. e-Pub 2018. PMID: 29128105.
Melamed A, Manning-Geist B, Bregar AJ, Diver EJ, Goodman A, Del Carmen MG, Schorge JO, Rauh-Hain JA. Associations between residual disease and survival in epithelial ovarian cancer by histologic type. Gynecol Oncol 147(2):250-256, 2017. e-Pub 2017. PMID: 28822556.
Melamed A, Rizzo AE, Nitecki R, Gockley AA, Bregar AJ, Schorge JO, Del Carmen MG, Rauh-Hain JA. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer. Obstet Gynecol 130(1):71-79, 2017. e-Pub 2017. PMID: 28594773.
Bregar AJ, Melamed A, Diver E, Clemmer JT, Uppal S, Schorge JO, Rice LW, Del Carmen MG, Rauh-Hain JA. Minimally Invasive Staging Surgery in Women with Early-Stage Endometrial Cancer: Analysis of the National Cancer Data Base. Ann Surg Oncol 24(6):1677-1687, 2017. e-Pub 2017. PMID: 28074326.
Melamed A, Nitecki R, Boruta DM, Del Carmen MG, Clark RM, Growdon WB, Goodman A, Schorge JO, Rauh-Hain JA. Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy. Obstet Gynecol 129(5):861-869, 2017. e-Pub 2017. PMID: 28383367.
Bregar AJ, Rauh-Hain JA, Spencer R, Clemmer JT, Schorge JO, Rice LW, Del Carmen MG. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis. Gynecol Oncol 145(1):114-121, 2017. e-Pub 2017. PMID: 28159409.
Gockley A, Melamed A, Bregar AJ, Clemmer JT, Birrer M, Schorge JO, Del Carmen MG, Rauh-Hain JA. Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer. Obstet Gynecol 129(3):439-447, 2017. e-Pub 2017. PMID: 28178043.
Uppal S, Chapman C, Spencer RJ, Jolly S, Maturen K, Rauh-Hain JA, delCarmen MG, Rice LW. Association of Hospital Volume With Racial and Ethnic Disparities in Locally Advanced Cervical Cancer Treatment. Obstet Gynecol 129(2):295-304, 2017. e-Pub 2017. PMID: 28079775.
Dorney KM, Growdon WB, Clemmer J, Rauh-Hain JA, Hall TR, Diver E, Boruta D, Del Carmen MG, Goodman A, Schorge JO, Horowitz N, Clark RM. Patient, treatment and discharge factors associated with hospital readmission within 30days after surgery for vulvar cancer. Gynecol Oncol 144(1):136-139, 2017. e-Pub 2017. PMID: 27836203.
Rauh-Hain JA, Melamed A, Wright A, Gockley A, Clemmer JT, Schorge JO, Del Carmen MG, Keating NL. Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database. JAMA Oncol 3(1):76-82, 2017. e-Pub 2017. PMID: 27892998.
Melamed A, Keating NL, Clemmer JT, Bregar AJ, Wright JD, Boruta DM, Schorge JO, Del Carmen MG, Rauh-Hain JA. Laparoscopic staging for apparent stage I epithelial ovarian cancer. Am J Obstet Gynecol 216(1):50.e1-50.e12, 2017. e-Pub 2017. PMID: 27567562.
Del Carmen MG, Supko JG, Horick NK, Rauh-Hain JA, Clark RM, Campos SM, Krasner CN, Atkinson T, Birrer MJ. Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer. Cancer 122(21):3297-3306, 2016. e-Pub 2016. PMID: 27421044.
Melamed A, Hinchcliff EM, Clemmer JT, Bregar AJ, Uppal S, Bostock I, Schorge JO, Del Carmen MG, Rauh-Hain JA. Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States. Gynecol Oncol 143(2):236-240, 2016. e-Pub 2016. PMID: 27612977.
Penn CA, Morgan DM, Rice LW, Harris JA, Rauh-Hain JA, Uppal S. Timing of and Reasons for Unplanned 30-Day Readmission After Hysterectomy for Benign Disease. Obstet Gynecol 128(4):889-97, 2016. e-Pub 2016. PMID: 27607868.
Foley OW, Rauh-Hain JA, Clark RM, Goodman A, Growdon WB, Boruta DM, Schorge JO, Del Carmen MG. Intraoperative Radiation Therapy in the Management of Gynecologic Malignancies. Am J Clin Oncol 39(4):329-34, 2016. e-Pub 2016. PMID: 24685883.
Uppal S, Del Carmen MG, Rice LW, Reynolds RK, Jolly S, Bregar A, Abdelsattar ZM, Rauh-Hain JA. Variation in care in concurrent chemotherapy administration during radiation for locally advanced cervical cancer. Gynecol Oncol 142(2):286-92, 2016. e-Pub 2016. PMID: 27234144.
Davis M, Aviki E, Rauh-Hain JA, Worley M, Berkowitz R, Schorge J, Muto M, Clark Sisodia R, Horowitz N, Del Carmen M. Investigating the Impact of Body Mass Index on Intraperitoneal Chemotherapy Outcomes in Ovarian and Fallopian Tube Cancer. Int J Gynecol Cancer 26(6):1033-40, 2016. e-Pub 2016. PMID: 27206282.
Rauh-Hain JA, Gonzalez R, Bregar AJ, Clemmer J, Hernández-Blanquisett A, Clark RM, Schorge JO, Del Carmen MG. Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: A National Cancer Database analysis. Gynecol Oncol 142(1):38-43, 2016. e-Pub 2016. PMID: 27107722.
Uppal S, Penn C, Del Carmen MG, Rauh-Hain JA, Reynolds RK, Rice LW. Readmissions after major gynecologic oncology surgery. Gynecol Oncol 141(2):287-292, 2016. e-Pub 2016. PMID: 26927757.
Gockley AA, Rauh-Hain JA, Anders AM, Meyer LA, Clemmer J, Lu KH, Clark RM, Schorge JO, del Carmen MG. Patterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis. Int J Gynecol Cancer 26(4):697-704, 2016. e-Pub 2016. PMID: 26825834.
Hinchcliff EM, Esselen KM, Watkins JC, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Quade BJ, Muto MG. The Role of Endometrial Biopsy in the Preoperative Detection of Uterine Leiomyosarcoma. J Minim Invasive Gynecol 23(4):567-72, 2016. e-Pub 2016. PMID: 26851414.
Hinchcliff E, Rauh-Hain JA, Clemmer JT, Diver E, Hall T, Stall J, Growdon W, Clark R, Schorge J. Racial disparities in survival in malignant germ cell tumors of the ovary. Gynecol Oncol 140(3):463-9, 2016. e-Pub 2016. PMID: 26773470.
Rauh-Hain JA, Vargas RJ, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis. Am J Clin Oncol 39(1):43-8, 2016. e-Pub 2016. PMID: 24390270.
Oduyebo T, Hinchcliff E, Meserve EE, Seidman MA, Quade BJ, Rauh-Hain JA, George S, Nucci MR, del Carmen MG, Muto MG. Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic Surgery. J Minim Invasive Gynecol 23(1):34-9, 2016. e-Pub 2016. PMID: 26253281.
Rauh-Hain JA, Pepin KJ, Meyer LA, Clemmer JT, Lu KH, Rice LW, Uppal S, Schorge JO, Del Carmen MG. Management for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer. Obstet Gynecol 126(6):1198-206, 2015. e-Pub 2015. PMID: 26551187.
Foley OW, Birrer N, Rauh-Hain JA, Clark RM, DiTavi E, Del Carmen MG. Effect of Educational Intervention on Cervical Cancer Prevention and Screening in Hispanic Women. J Community Health 40(6):1178-84, 2015. e-Pub 2015. PMID: 26026277.
Melamed A, Rauh-Hain JA, Clemmer JT, Diver EJ, Hall TR, Clark RM, Uppal S, Goodman A, Boruta DM. Changing Trends in Lymphadenectomy for Endometrioid Adenocarcinoma of the Endometrium. Obstet Gynecol 126(4):815-22, 2015. e-Pub 2015. PMID: 26348192.
Rauh-Hain JA, Diver E, Meyer LA, Clemmer J, Lu KH, Del Carmen MG, Schorge JO. Patterns of care, associations and outcomes of chemotherapy for uterine serous carcinoma: analysis of the National Cancer Database. Gynecol Oncol 139(1):77-83, 2015. e-Pub 2015. PMID: 26325526.
Rauh-Hain JA, Starbuck KD, Meyer LA, Clemmer J, Schorge JO, Lu KH, Del Carmen MG. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis. Gynecol Oncol 139(1):84-9, 2015. e-Pub 2015. PMID: 26307402.
Rauh-Hain JA, Connor SC, Clemmer JT, Foley OW, Clark RM, Hall TR, Boruta DM, Schorge JO, del Carmen MG. Trends in Treatment of Uterine Serous Cancer in the Medicare Population. Int J Gynecol Cancer 25(6):1023-30, 2015. e-Pub 2015. PMID: 25914960.
Ghezelayagh T, Rauh-Hain JA, Growdon WB. Comparing mortality of vaginal sarcoma, squamous cell carcinoma, and adenocarcinoma in the surveillance, epidemiology, and end results database. Obstet Gynecol 125(6):1353-61, 2015. e-Pub 2015. PMID: 26000506.
Rauh-Hain JA, Hariton E, Clemmer J, Clark RM, Hall T, Boruta DM, Schorge JO, Del Carmen MG. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer. Obstet Gynecol 125(6):1362-70, 2015. e-Pub 2015. PMID: 26000507.
Rauh-Hain JA, Foley OW, Winograd D, Andrade C, Clark RM, Vargas RJ, Hinchcliff EM, Esselen KM, Horowitz NS, del Carmen MG. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer. Am J Obstet Gynecol 212(5):600.e1-8, 2015. e-Pub 2015. PMID: 25514761.
Rauh-Hain JA, Buskwofie A, Clemmer J, Boruta DM, Schorge JO, del Carmen MG. Racial disparities in treatment of high-grade endometrial cancer in the Medicare population. Obstet Gynecol 125(4):843-51, 2015. e-Pub 2015. PMID: 25751197.
Aviki EM, Rauh-Hain JA, Clark RM, Hall TR, Berkowitz LR, Boruta DM, Growdon WB, Schorge JO, Goodman A. Gynecologic Oncologist as surgical consultant: intraoperative consultations during general gynecologic surgery as an important focus of gynecologic oncology training. Gynecol Oncol 137(1):93-7, 2015. e-Pub 2015. PMID: 25617772.
Foley OW, Rauh-Hain JA, Clemmer J, Clark RM, Hall T, Diver EJ, Schorge JO, del Carmen MG. Trends in the treatment of uterine leiomyosarcoma in the Medicare population. Int J Gynecol Cancer 25(3):453-8, 2015. e-Pub 2015. PMID: 25628107.
Linkov F, Edwards RP, Althouse A, Rauh-Hain JA, Del Carmen MG, Freese KE, Kelley JL, Olawaiye AB. Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients. Future Oncol 11(4):607-15, 2015. e-Pub 2015. PMID: 25686116.
Rauh-Hain JA, Goodman A, Boruta DM, Schorge JO, Horowitz NS, del Carmen MG. Endometrial stromal sarcoma: a clinicopathologic study of 29 patients. J Reprod Med 59(11-12):547-52, 2014. e-Pub 2014. PMID: 25552126.
Owusu-Darko S, Rauh-Hain JA, Horowitz NS, Goodman A, Schorge JO, Del Carmen MG. Comparison of outcomes in patients with early-stage mucinous endometrial cancer and those with endometrioid endometrial cancer, with and without adjuvant therapy. J Reprod Med 59(11-12):527-33, 2014. e-Pub 2014. PMID: 25552123.
George S, Barysauskas C, Serrano C, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Demetri GD, Muto MG. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. Cancer 120(20):3154-8, 2014. e-Pub 2014. PMID: 24923260.
Rauh-Hain JA, Hinchcliff EM, Oduyebo T, Worley MJ, Andrade CA, Schorge JO, George S, Muto MG, del Carmen MG. Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma. Int J Gynecol Cancer 24(8):1434-40, 2014. e-Pub 2014. PMID: 25248114.
Worley MJ, Guseh SH, Rauh-Hain JA, Esselen KM, Muto MG, Feltmate CM, Berkowitz RS, Del Carmen MG, Schorge JO, Horowitz NS. What is the optimal treatment for obese patients with advanced ovarian carcinoma?. Am J Obstet Gynecol 211(3):231.e1-9, 2014. e-Pub 2014. PMID: 24704062.
Eskander RN, Osann K, Dickson E, Holman LL, Rauh-Hain JA, Spoozak L, Wu E, Krill L, Fader AN, Tewari KS. Assessment of palliative care training in gynecologic oncology: a gynecologic oncology fellow research network study. Gynecol Oncol 134(2):379-84, 2014. e-Pub 2014. PMID: 24887355.
Rauh-Hain JA, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Dizon DS, Schorge JO, del Carmen MG. Management and outcomes for elderly women with vulvar cancer over time. BJOG 121(6):719-27; discussion 727, 2014. e-Pub 2014. PMID: 24621118.
Vargas R, Rauh-Hain JA, Clemmer J, Clark RM, Goodman A, Growdon WB, Schorge JO, Del Carmen MG, Horowitz NS, Boruta DM. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecol Oncol 133(2):216-20, 2014. e-Pub 2014. PMID: 24548726.
Bradford LS, Rauh-Hain JA, Clark RM, Groeneweg JW, Zhang L, Borger D, Zukerberg LR, Growdon WB, Foster R, Rueda BR. Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer. Gynecol Oncol 133(2):346-52, 2014. e-Pub 2014. PMID: 24561032.
Guseh SH, Rauh-Hain JA, Tambouret RH, Davis M, Clark RM, Boruta DM, Goodman A, Growdon WB, Schorge JO, del Carmen MG. Transitional cell carcinoma of the ovary: a case-control study. Gynecol Oncol 132(3):649-53, 2014. e-Pub 2014. PMID: 24462804.
Oduyebo T, Rauh-Hain JA, Meserve EE, Seidman MA, Hinchcliff E, George S, Quade B, Nucci MR, Del Carmen MG, Muto MG. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Gynecol Oncol 132(2):360-5, 2014. e-Pub 2014. PMID: 24296345.
Rauh-Hain JA, Rauh-Hain JA, Clemmer J, Clemmer J, Clark RM, Clark RM, Bradford LS, Bradford LS, Growdon WB, Growdon WB, Goodman A, Goodman A, Boruta DM, Boruta DM, Schorge JO, Schorge JO, del Carmen MG, del Carmen MG. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time. Am J Obstet Gynecol 209(5):468.e1-468.e10, 2013. e-Pub 2013. PMID: 23891626.
Rauh-Hain JA, Davis M, Clemmer J, Clark RM, Growdon WB, Goodman AK, Boruta DM, Schorge JO, del Carmen MG. Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis. Gynecol Oncol 131(2):404-9, 2013. e-Pub 2013. PMID: 24004647.
Rauh-Hain JA, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Racial disparities in cervical cancer survival over time. Cancer 119(20):3644-52, 2013. e-Pub 2013. PMID: 23913530.
Rauh-Hain JA, Diver EJ, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman AK, Boruta DM, Schorge JO, del Carmen MG. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis. Gynecol Oncol 131(1):46-51, 2013. e-Pub 2013. PMID: 23906658.
Rauh-Hain JA, Guseh SH, Esselen KM, Growdon WB, Schorge JO, Horowitz NS, Krasner CN, del Carmen MG, Birrer MJ, Dizon DS. Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer. Int J Gynecol Cancer 23(7):1219-25, 2013. e-Pub 2013. PMID: 23975042.
Clark RM, Growdon WB, Wiechert A, Boruta D, Del Carmen M, Goodman AK, Bradford L, Rauh-Hain JA, Schorge JO. Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma. Gynecol Oncol 130(3):407-10, 2013. e-Pub 2013. PMID: 23747329.
Barroilhet L, Yang J, Hasselblatt K, Paranal RM, Ng SK, Rauh-Hain JA, Welch WR, Bradner JE, Berkowitz RS, Ng SW. C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors. Oncogene 32(33):3896-903, 2013. e-Pub 2013. PMID: 22945647.
Rauh-Hain JA, Oduyebo T, Diver EJ, Guseh SH, George S, Muto MG, del Carmen MG. Uterine leiomyosarcoma: an updated series. Int J Gynecol Cancer 23(6):1036-43, 2013. e-Pub 2013. PMID: 23714705.
Rauh-Hain JA, Shoni M, Schorge JO, Goodman A, Horowitz NS, del Carmen MG. Prognostic determinants in patients with uterine and ovarian carcinosarcoma. J Reprod Med 58(7-8):297-304, 2013. e-Pub 2013. PMID: 23947079.
Rauh-Hain JA, Nitschmann CC, Worley MJ, Bradford LS, Berkowitz RS, Schorge JO, Campos SM, del Carmen MG, Horowitz NS. Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. Gynecol Oncol 129(1):63-8, 2013. e-Pub 2013. PMID: 23337490.
Worley MJ, Guseh SH, Rauh-Hain JA, Williams KA, Muto MG, Feltmate CM, Berkowitz RS, Horowitz NS. Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery?. Gynecol Oncol 129(1):69-73, 2013. e-Pub 2013. PMID: 23375727.
Worley MJ, Nitschmann CC, Shoni M, Rauh-Hain JA, Williams KA, Feltmate CM. Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma. Int J Gynecol Cancer 23(2):312-7, 2013. e-Pub 2013. PMID: 23358179.
Worley MJ, Rauh-Hain JA, Sandberg EM, Muto MG. Venous thromboembolism prophylaxis for laparoscopic surgery: a survey of members of the Society of Gynecologic Oncology. Int J Gynecol Cancer 23(1):208-15, 2013. e-Pub 2013. PMID: 23221603.
Smith AL, Krivak TC, Scott EM, Rauh-Hain JA, Sukumvanich P, Olawaiye AB, Richard SD. Dual-console robotic surgery compared to laparoscopic surgery with respect to surgical outcomes in a gynecologic oncology fellowship program. Gynecol Oncol 126(3):432-6, 2012. e-Pub 2012. PMID: 22613352.
Rodriguez N, Yang J, Hasselblatt K, Liu S, Zhou Y, Rauh-Hain JA, Ng SK, Choi PW, Fong WP, Agar NY, Welch WR, Berkowitz RS, Ng SW. Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells. EMBO Mol Med 4(9):952-63, 2012. e-Pub 2012. PMID: 22707389.
Worley MJ, Nitschmann CC, Shoni M, Vitonis AF, Rauh-Hain JA, Feltmate CM. The significance of preoperative leukocytosis in endometrial carcinoma. Gynecol Oncol 125(3):561-5, 2012. e-Pub 2012. PMID: 22465698.
Rauh-Hain JA, Winograd D, Growdon WB, Schorge JO, Goodman AK, Boruta DM, Berkowitz RS, Horowitz NS, Del Carmen MG. Prognostic determinants in patients with uterine and ovarian clear carcinoma. Gynecol Oncol 125(2):376-80, 2012. e-Pub 2012. PMID: 22366593.
Rodriguez N, Rauh-Hain JA, Shoni M, Berkowitz RS, Muto MG, Feltmate C, Schorge JO, Del Carmen MG, Matulonis UA, Horowitz NS. Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol 125(2):362-6, 2012. e-Pub 2012. PMID: 22333992.
Rauh-Hain JA, Growdon WB, Braga A, Goldstein DP, Berkowitz RS. Gestational trophoblastic neoplasia in adolescents. J Reprod Med 57(5-6):237-42, 2012. e-Pub 2012. PMID: 22696819.
Rauh-Hain JA, Rodriguez N, Growdon WB, Goodman AK, Boruta DM, Horowitz NS, del Carmen MG, Schorge JO. Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer. Ann Surg Oncol 19(3):959-65, 2012. e-Pub 2012. PMID: 21994038.
Growdon WB, Rauh-Hain JA, Cordon A, Garrett L, Schorge JO, Goodman A, Boruta DM, Horowitz NS, del Carmen MG. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review. Int J Gynecol Cancer 22(3):417-24, 2012. e-Pub 2012. PMID: 22237383.
Diver EJ, Rauh-Hain JA, Del Carmen MG. Total pelvic exenteration for gynecologic malignancies. Int J Surg Oncol 2012:693535, 2012. e-Pub 2012. PMID: 22720150.
Olawaiye AB, Godoy HE, Shahzad MM, Rauh-Hain JA, Lele SB, Odunsi K. Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancer. Eur J Gynaecol Oncol 33(5):477-9, 2012. e-Pub 2012. PMID: 23185791.
Rauh-Hain JA, Growdon WB, Rodriguez N, Goodman AK, Boruta DM, Schorge JO, Horowitz NS, del Carmen MG. Carcinosarcoma of the ovary: a case-control study. Gynecol Oncol 121(3):477-81, 2011. e-Pub 2011. PMID: 21420726.
Rauh-Hain JA, Laufer MR. Increased diagnostic accuracy of laparoscopy in endometriosis using indigo carmine: a new technique. Fertil Steril 95(3):1113-4, 2011. e-Pub 2011. PMID: 21227413.
Rauh-Hain JA, Krivak TC, Del Carmen MG, Olawaiye AB. Ovarian cancer screening and early detection in the general population. Rev Obstet Gynecol 4(1):15-21, 2011. e-Pub 2011. PMID: 21629494.
Rauh-Hain JA, Growdon WB, Schorge JO, Goodman AK, Boruta DM, McCann C, Horowitz NS, del Carmen MG. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma. Gynecol Oncol 119(2):299-304, 2010. e-Pub 2010. PMID: 20691465.
Steinberg G, Lee C, Rauh-Hain JA, Ecker J, Khankin EV, Hsu CD, Cohen B, Rana S, Karumanchi SA, Thadhani R, Hacker MR, Lim KH. Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies. Am J Obstet Gynecol 202(3):299.e1-7, 2010. e-Pub 2010. PMID: 20207247.
Rauh-Hain JA, Olawaiye AB, Munro M, Ko E, Alarcon IA, Del Carmen MG, Duska L. Role of computed tomography in the surgical management of patients with bowel obstruction secondary to recurrent ovarian carcinoma. Ann Surg Oncol 17(3):853-60, 2010. e-Pub 2010. PMID: 20183913.
Rauh-Hain JA, del Carmen M, Horowitz NS, Alarcon IA, Ko E, Goodman AK, Olawaiye AB. Impact of bowel obstruction at the time of initial presentation in women with ovarian cancer. BJOG 117(1):32-8, 2010. e-Pub 2010. PMID: 20002368.
Rauh-Hain JA, Costaaggini I, Olawaiye AB, Growdon WB, Horowitz NS, del Carmen MG. A comparison of outcome in patients with stage 1 clear cell and grade 3 endometrioid adenocarcinoma of the endometrium with and without adjuvant therapy. Eur J Gynaecol Oncol 31(3):284-7, 2010. e-Pub 2010. PMID: 21077469.
Watts L, Joseph N, Velazquez A, Gonzalez M, Munro E, Muzikansky A, Rauh-Hain JA, Del Carmen MG. Understanding barriers to cervical cancer screening among Hispanic women. Am J Obstet Gynecol 201(2):199.e1-8, 2009. e-Pub 2009. PMID: 19646571.
Rauh-Hain JA, Rana S, Tamez H, Wang A, Cohen B, Cohen A, Brown F, Ecker JL, Karumanchi SA, Thadhani R. Risk for developing gestational diabetes in women with twin pregnancies. J Matern Fetal Neonatal Med 22(4):293-9, 2009. e-Pub 2009. PMID: 19340713.
Watts LA, Joseph N, Wallace M, Rauh-Hain JA, Muzikansky A, Growdon WB, del Carmen MG. HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecol Oncol 112(3):577-82, 2009. e-Pub 2009. PMID: 19150120.
Olawaiye AB, Rauh-Hain JA, Withiam-Leitch M, Rueda B, Goodman A, del Carmen MG. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma. Gynecol Oncol 110(3):293-8, 2008. e-Pub 2008. PMID: 18644620.
Rauh-Hain JA, Penson RT. Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma. Int J Gynecol Cancer 18(5):934-6, 2008. e-Pub 2008. PMID: 18081793.
Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359(6):584-92, 2008. e-Pub 2008. PMID: 18687639.
Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 50(1):137-42, 2007. e-Pub 2007. PMID: 17515455.

Invited Articles

Bercow A, Del Carmen MG, Rauh-Hain JA, Melamed A. Role of Minimally Invasive Techniques in the Management of Early-Stage Carcinoma of the Uterine Cervix. J Clin Oncol 42(23):JCO2400656, 2024. e-Pub 2024. PMID: 38917386.
Armbruster S, Coleman RL, Rauh-Hain JA. Management and Treatment of Recurrent Epithelial Ovarian Cancer. Hematol Oncol Clin North Am 32(6):965-982, 2018. e-Pub 2018. PMID: 30390768.
Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PE, Soto-Perez-de-Celis E, Dizon D, Cazap E, de Lima Lopes G, Touya D, Nunes JS, St Louis J, Vail C, Bukowski A, Ramos-Elias P, Unger-Saldaña K, Brandao DF, Ferreyra ME, Luciani S, Nogueira-Rodrigues A, de Carvalho Calabrich AF, Del Carmen MG, Rauh-Hain JA, Schmeler K, Sala R, Goss PE. Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol 16(14):1405-38, 2015. e-Pub 2015. PMID: 26522157.
Bradford LS, Rauh-Hain JA, Schorge J, Birrer MJ, Dizon DS. Advances in the management of recurrent endometrial cancer. Am J Clin Oncol 38(2):206-12, 2015. e-Pub 2015. PMID: 23764681.
Rauh-Hain JA, Melamed A, Buskwofie A, Schorge JO. Adnexal mass in the postmenopausal patient. Clin Obstet Gynecol 58(1):53-65, 2015. e-Pub 2015. PMID: 25565080.
Foley OW, Rauh-Hain JA, del Carmen MG. Recurrent epithelial ovarian cancer: an update on treatment. Oncology (Williston Park) 27(4):288-94, 298, 2013. e-Pub 2013. PMID: 23781692.
Schorge JO, Rauh-Hain JA. Atypical glandular cells. Clin Obstet Gynecol 56(1):35-43, 2013. e-Pub 2013. PMID: 23314725.
Penson RT, Rauh-Hain JA, Horowitz NS. Antiangiogenic Therapy and Ovarian Cancer. Current Women's Health Reviews. Current Women's Health Reviews 4(1):33-44, 2008. e-Pub 2008.

Review Articles

Beshar I, Agusti N, Barajas K, Krause K, Nitecki Wilke R, Rauh-Hain JA. Barriers and interventions to improve the uptake of cancer risk management strategies in hereditary cancer syndromes: a narrative review. Int J Gynecol Cancer 36(1):102825, 2026. e-Pub 2026. PMID: 41494213.
Kanbergs A, Rauh-Hain JA, Wilke RN. Differential Receipt of Genetic Services Among Patients With Gynecologic Cancer and Their Relatives: A Review of Challenges to Health Equity. Clin Obstet Gynecol 67(4):666-671, 2024. e-Pub 2024. PMID: 39331025.
Hicks-Courant K, Ko EM, Matsuo K, Melamed A, Nasioudis D, Rauh-Hain JA, Uppal S, Wright JD, Ramirez PT. Secondary databases in gynecologic cancer research. Int J Gynecol Cancer 34(10):1619-1629, 2024. e-Pub 2024. PMID: 39043573.
Manning, W, Li, S, Bregar, AJ, Gockley, AA, Clapp, MC, Wilke, RN, Dioun, SM, Rauh-Hain, JA, Melamed, A. Assessing the risk of uterine serous carcinoma in survivors of triple-negative breast cancer. Journal of Clinical Oncology 42:5602, 2024. e-Pub 2024.
Angeles MA, De Vitis LA, Cucinella G, Bonaldo G, Bizzarri N, Agusti N, Kacperczyk-Bartnik J, El Hajj H, Theofanakis C, Bilir E, Hsu HC, Estrada EE, Pareja R, Fotopoulou C, du Bois A, Plante M, Rauh-Hain JA, Mirza MR, Monk BJ, Gultekin M, Joura E, Fagotti A, Ramirez PT. Highlights from the 24th European Congress on Gynaecological Oncology in Istanbul: an ENYGO-IJGC Fellows compilation. Int J Gynecol Cancer 34(2):190-196, 2023. e-Pub 2023. PMID: 38114163.
Agusti, N, Viveros-Carreño, D, Mora-Soto, N, Ramirez, PT, Rauh-Hain, JA, Wu, C, Rodriguez, J, Grillo - Ardila, CF, Salazar, C, Jorgensen, K, Segarra, B, Chacón, E, Melamed, A, Pareja, R. Diagnostic accuracy of sentinel lymph node frozen section analysis in patients with early-stage cervical cancer. Gynecologic oncology 177:157-164, 2023. e-Pub 2023. PMID: 37703622.
Vergote I, Gonzalez-Martin A, Lorusso D, Gourley C, Mirza MR, Kurtz JE, Okamoto A, Moore K, Kridelka F, McNeish I, Reuss A, Votan B, du Bois A, Mahner S, Ray-Coquard I, Kohn EC, Berek JS, Tan DSP, Colombo N, Zang R, Concin N, O'Donnell D, Rauh-Hain JA, Herrington CS, Marth C, Poveda A, Fujiwara K, Stuart GCE, Oza AM, Bookman MA, Clinical Research POT6GCI(OCCCO. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. Lancet Oncol 23(8):e374-e384, 2022. e-Pub 2022. PMID: 35901833.
Bednar EM, Nitecki R, Krause KJ, Rauh-Hain JA. Interventions to improve delivery of cancer genetics services in the United States: A scoping review. Genet Med 24(6):1176-1186, 2022. e-Pub 2022. PMID: 35389342.
Bercow A, Nitecki R, Brady PC, Rauh-Hain JA. Outcomes after Fertility-Sparing Surgery for Women with Ovarian Cancer: A Systematic Review of the Literature. J Minim Invasive Gynecol 28(3):527-536.e1, 2021. e-Pub 2021. PMID: 32861046.
Floyd JL, Campbell S, Rauh-Hain JA, Woodard T. Fertility preservation in women with early-stage gynecologic cancer: optimizing oncologic and reproductive outcomes. Int J Gynecol Cancer 31(3):345-351, 2021. e-Pub 2021. PMID: 32565487.
Wilke, RN, Woodard, TL, Rauh-Hain, JA. Fertility-Sparing Treatment for Early-Stage Cervical, Ovarian, and Endometrial Malignancies. Obstetrical and Gynecological Survey 76(7):406-408, 2021. e-Pub 2021. PMID: 33156194.
Hinchcliff EM, Bednar EM, Lu KH, Rauh-Hain JA. Disparities in gynecologic cancer genetics evaluation. Gynecol Oncol 153(1):184-191, 2019. e-Pub 2019. PMID: 30711300.
Melamed A, Rauh-Hain JA, Schorge JO. Clinical outcomes research in gynecologic oncology. Gynecol Oncol 146(3):653-660, 2017. e-Pub 2017. PMID: 28651803.
Rauh-Hain JA, Birrer M, Del Carmen MG. Carcinosarcoma of the ovary, fallopian tube, and peritoneum: Prognostic factors and treatment modalities. Gynecol Oncol 142(2):248-54, 2016. e-Pub 2016. PMID: 27321238.
Gockley AA, Rauh-Hain JA, del Carmen MG. Uterine leiomyosarcoma: a review article. Int J Gynecol Cancer 24(9):1538-42, 2014. e-Pub 2014. PMID: 25304676.
Davis M, Rauh-Hain JA, Andrade C, Boruta DM, Schorge JO, Horowitz NS, May T, del Carmen MG. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary. Gynecol Oncol 132(3):760-6, 2014. e-Pub 2014. PMID: 24440832.
Rauh-Hain JA, del Carmen MG. Endometrial stromal sarcoma: a systematic review. Obstet Gynecol 122(3):676-83, 2013. e-Pub 2013. PMID: 23921879.
Foley OW, Rauh-Hain JA, del Carmen MG. The role of intraoperative radiation therapy in the management of recurrent and locally advanced gynecologic cancers. Int J Gynecol Cancer 23(1):9-15, 2013. e-Pub 2013. PMID: 23187790.
Rauh-Hain JA, Del Carmen MG. Treatment for advanced and recurrent endometrial carcinoma: combined modalities. Oncologist 15(8):852-61, 2010. e-Pub 2010. PMID: 20660059.

Editorials

Hoffman AS, Rauh-Hain JA, Woodard TL. Preserving Fertility in Women With Cancer: Practice Strategies. JAMA Oncol 9(1):21-22, 2023. PMID: 36326749.
Dottino JA, Rauh-Hain JA. Financial toxicity: An adverse effect worthy of a black box warning?. Gynecol Oncol 156(2):263-264, 2020. PMID: 32046838.
Melamed A, Rauh-Hain JA. Minimally invasive interval cytoreductive surgery: it's time for a randomized trial. Int J Gynecol Cancer 29(9):1339-1340, 2019. PMID: 31685555.
Havrilesky L, Rauh-Hain JA. Health Services Research: Not just retrospective chart reviews. Gynecol Oncol 152(3):437-438, 2019. PMID: 30876485.
Rauh-Hain JA, Brewster WR, Behbakht K. Society of Gynecologic Oncology 2018 Annual Meeting on Women's Cancer: Meeting report. Gynecol Oncol 151(2):e7-e9, 2018. PMID: 30146111.

Book Chapters

Nitecki R, Cobb LP, Jazaeri AA, Rauh-Hain JA. Ovarian Cancer. In: The MD Anderson Manual of Medical Oncology - Fourth Edition. Fourth, 897-930, 2022.
Rauh-Hain JA, Carmen D, Dizon D, Birrer MJ. Gynecologic Cancer. In: Skeel's Handbook of Cancer Therapy. 9. Wolters Kluwer, 2016.
Rauh-Hain JA, Dizon DS. The Corpus: Epithelial tumors. In: Handbook for Principles and Practice of Gynecologic Oncology. 2nd. Wolters Kluwer, 153-183, 2015.
Schmeler KM, Rauh-Hain JA, Carmen D. Endometrial Stromal Sarcomas. In: Uncommon Gynecologic Cancers. 1. Wiley-Blackwell, 205-215, 2014.
Rauh-Hain JA, Carmen D. Carcinosarcoma of the Ovary. In: Uncommon Gynecologic Cancers. 1. Wiley-Blackwell, 109-119, 2014.
Rauh-Hain JA, Olawaiye AB, Boruta DM. Uterine Clear Cell Carcinoma. In: Uncommon Gynecologic Cancers. 1. Wiley-Blackwell, 186-194, 2014.
Clark RM, Rauh-Hain JA, Carmen D. Sarcomas of the Vulva and Vagina. In: Uncommon Gynecologic Cancers. 1. Wiley-Blackwell, 236-243, 2014.

Letters to the Editor

Viveros-Carreño, D, Garcia, NA, Pareja, R, Rauh-Hain, JA. In Reply. Obstetrics and gynecology 145: e139-e140, 2025.
Melamed A, Rauh-Hain JA. In Reply. Obstet Gynecol 130: 470, 2017.

Less

CV information above last modified March 18, 2026

Jose Alejandro Rauh-Hain, M.D., M.P.H.

About Dr. Jose Alejandro Rauh-Hain

In the News

2019 Andrew Sabin Family Fellows share passion for Making Cancer History

Minimally invasive surgery associated with worse survival for women with cervical cancer compared to open hysterectomy

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Clinical Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Intramural Institutional Committee Activities

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Other Articles

Editorials

Book Chapters

Letters to the Editor

Patient Reviews

Request an Appointment

Related Links

Gynecologic Oncology Center

Gynecologic Oncology & Reproductive Medicine Department

Health Services Research Department

Surgery Division

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson